Position in ALXO
as of Dec 31, 2025
· filed Feb 12, 2026
Position Value
$536,502
-$332,347 QoQ
Shares Held
474,781
0.0% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in ALXO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $536,502 | 474,781 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $868,849 | 474,781 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $277,530 | 668,747 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $425,131 | 682,394 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,380,391 | 826,582 | Shares | Defined | 2025-02-13 | |
| 2021-03-31 | $37,828 | 513 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $130,075 | 1,509 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $16,718 | 443 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||